An interventional study of Electro-acupuncture at the Jiaji points and Electro-acupuncture at the scalp points in Spinal Cord Injuries (SCI), sponsored by Hangzhou Medical College. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-07.
Sponsored by Hangzhou Medical College · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 80 studies in Spinal Cord Injuries with a site in China — 26 open to participants now, 32 under way, none of them phase 3. Spinal Cord Injuries · China.
Among the 80 studies in Spinal Cord Injuries with a site in China, this one is the 13th largest by enrollment of the 71 interventional ones that give a count, is one of 9 that started in 2024, is one of 44 with no phase, and was the 50th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →26 of the 80 studies in Spinal Cord Injuries with a site in China are open now. Recruiting first, the newest first:
BCIFlex Medical Technology Co., Ltd. · Sites in China
Ages 18–65
NeuroXess Technology (shanghai) Co.,Ltd. · Sites in China
Ages 18–65
Shengjing Hospital · Sites in China
Ages 18–80
Zhongda Hospital · Sites in China
Ages 18–75
Shanghai StairMed Technology Co., Ltd. · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
80 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 16 · Phase 2 17 · Phase 3 2 · Phase 4 1
First in 2000; this study’s year is marked. 9 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 84 is above the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 36 across the 71 interventional studies, 107 across the 9 observational. Of the 23 that completed or were terminated, 3 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 80 have an industry lead sponsor. The 10 most frequent:
Hangzhou Medical College is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Hangzhou Medical College has 1 study filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
15 of the studies in Spinal Cord Injuries with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07900490Hainan UniversityRecovery and Safety After Epidural Spinal Cord Stimulation in People With Spinal Cord Injury | 2026-11-30 |
| NCT06436716Affiliated 2 Hospital of Nantong UniversityArtificial Intelligence Model for Traumatic Cervical Spinal Cord Injury Based on Radiomics and Genomics | 2026-12 |
| NCT07207798Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEpidural Electrical Stimulation in Spinal Cord Injury (T11-L3) | 2026-12-30 |
| NCT07907952Beijing Tsinghua Chang Gung HospitaltSCS Combined With Rehabilitation Training in Treating Paraplegic Patients After SCI | 2026-12-31 |
| NCT07105878Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEpidural Electrical Stimulation in Spinal Cord Injury | 2026-12-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 80 studies in Spinal Cord Injuries with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Spinal cord injury (SCI), leads to functional deficits and complications like neurogenic bladder and deep vein thrombosis, imposing a global annual financial burden. This trial aims to compares Jiaji electroacupuncture (JEA) and scalp electroacupuncture (SEA) in SCI rehabilitation. This randomized controlled trial (RCT) compared JEA and SEA in SCI rehabilitation.
The motor function score, light touch score, and pinprick sensation score of both groups showed significant improvement ( P \< 0.001). When comparing Group A and Group B, there was no statistically significant difference in ASIA grade improvement at week 4 ( P > 0.05), but at week 8 and the 3-month follow-up, the proportion of ASIA grade improvement in Group A was significantly higher than that in Group B (week 8: 40.48% vs. 14.29%, P=0.007; 3-month follow-up: 47.62% vs. 21.43%, P = 0.012). At week 4, week 8, and the 3-month follow-up, Group A's motor function score, light touch score, pinprick sensation score, and MBI were all higher than those of Group B ( P \< 0.05).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Recruiting patients receiving electro-acupuncture at the Scalp points
Other: Electro-acupuncture at the scalp points
Recruited patients receiving electro-acupuncture at the Jiaji points
Other: Electro-acupuncture at the Jiaji points
Adopting treatments for the group that received electro-acupuncture at the Jiaji points, including: ① electro-acupuncture at the Jiaji points with continuous treatment for 8 weeks.
Adopting treatments for the group that received electro-acupuncture at the Scalp points, including: ① electro-acupuncture at the Scalp points with continuous treatment for 8 weeks.
ASIA Score
The ASIA score for spinal cord injury, established by the American Spinal Injury Association, serves as a method to assess the severity of spinal cord injuries and functional recovery. It includes evaluations of the patient's neurological motor function, light touch sensation score, pinprick sensation score, and sphincter function performance. The ASIA score categorizes spinal cord injuries into five grades: 1/A, 2/B, 3/C, 4/D, and 5/E. A lower grade indicates a more severe injury, characterized by weaker motor and sensory scores, including light touch and pinprick sensation scores.
Time frame: 0 week, 4 weeks, 8 weeks, and 3 months of follow-up (3 months after the end of treatment)
Modified Barthel Index
The Modified Barthel Index Rating Scale is a tool used to assess adults' abilities to perform activities of daily living. It comprises 10 assessment items, including feeding, bathing, grooming, dressing, and controlling bowel and bladder movements. Each item is divided into different levels corresponding to various scores, with a maximum score of 100. A score of ≥60 indicates mild functional impairment, a score of 59-41 indicates moderate functional impairment, and a score of ≤40 indicates severe functional impairment.
Time frame: 0 week, 4 weeks, 8 weeks, and 3 months of follow-up (3 months after the end of treatment)
Incidence of Complications
Monitor whether patients experience severe bleeding, pressure ulcers, deep vein thrombosis, neurogenic bowel dysfunction, neurogenic bladder, nephropathy, pulmonary infections, traumatic encephalopathy, pain, and other complications during the treatment and follow-up periods. Record the number of patients with each type of complication. The incidence rate of complications is calculated as follows: (Total number of cases with a specific complication in each group) ÷ (Total number of patients in that group) × 100%.
Time frame: 0 week, 4 weeks, 8 weeks, and 3 months of follow-up (3 months after the end of treatment)
Ran from May 2024 to primary completion in Mar 2025, 10 months.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's 10 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hangzhou Medical College